357 related articles for article (PubMed ID: 37071471)
41. Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.
Burns SS; Kapur R
Stem Cell Reports; 2020 Aug; 15(2):292-306. PubMed ID: 32735822
[TBL] [Abstract][Full Text] [Related]
42. New Insights from Studies of Clonal Hematopoiesis.
Gibson CJ; Steensma DP
Clin Cancer Res; 2018 Oct; 24(19):4633-4642. PubMed ID: 29703819
[TBL] [Abstract][Full Text] [Related]
43. Clonal Hematopoiesis: Origins and determinants of evolution.
Mendez LM; Patnaik MM
Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
[TBL] [Abstract][Full Text] [Related]
44. [Clonal hematopoiesis: causes and clinical implications].
Burchert A
Z Gerontol Geriatr; 2023 Feb; 56(1):65-72. PubMed ID: 36662242
[TBL] [Abstract][Full Text] [Related]
45. CHIP: is clonal hematopoiesis a surrogate for aging and other disease?
Gondek LP
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):384-389. PubMed ID: 34889429
[TBL] [Abstract][Full Text] [Related]
46. Clonal hematopoiesis: Pre-cancer PLUS.
Silver AJ; Jaiswal S
Adv Cancer Res; 2019; 141():85-128. PubMed ID: 30691686
[TBL] [Abstract][Full Text] [Related]
47. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
48. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
Kunimoto H; Nakajima H
Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
[TBL] [Abstract][Full Text] [Related]
50. High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential.
Busque L; Sun M; Buscarlet M; Ayachi S; Feroz Zada Y; Provost S; Bourgoin V; Mollica L; Meisel M; Hinterleitner R; Jabri B; Dubé MP; Tardif JC
Blood Adv; 2020 Jun; 4(11):2430-2438. PubMed ID: 32492156
[TBL] [Abstract][Full Text] [Related]
51. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.
Misaka T; Kimishima Y; Yokokawa T; Ikeda K; Takeishi Y
J Cardiol; 2023 Jan; 81(1):3-9. PubMed ID: 35165011
[TBL] [Abstract][Full Text] [Related]
52. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors.
Fuster JJ
Thromb Res; 2022 May; 213 Suppl 1():S107-S112. PubMed ID: 36210552
[TBL] [Abstract][Full Text] [Related]
53. Clonal hematopoiesis: Molecular basis and clinical relevance.
Kunimoto H; Nakajima H
Leuk Res; 2020 Nov; 98():106457. PubMed ID: 33010619
[TBL] [Abstract][Full Text] [Related]
54. Clinical Implications of Clonal Hematopoiesis.
Steensma DP
Mayo Clin Proc; 2018 Aug; 93(8):1122-1130. PubMed ID: 30078412
[TBL] [Abstract][Full Text] [Related]
55. Evidence of Clonal Hematopoiesis and Risk of Heart Failure.
Bazeley P; Morales R; Tang WHW
Curr Heart Fail Rep; 2020 Oct; 17(5):271-276. PubMed ID: 32772279
[TBL] [Abstract][Full Text] [Related]
56. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
[TBL] [Abstract][Full Text] [Related]
57. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm.
Gaulin C; Kelemen K; Arana Yi C
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013314
[TBL] [Abstract][Full Text] [Related]
58. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis.
Kim PG; Niroula A; Shkolnik V; McConkey M; Lin AE; Słabicki M; Kemp JP; Bick A; Gibson CJ; Griffin G; Sekar A; Brooks DJ; Wong WJ; Cohen DN; Uddin MM; Shin WJ; Pirruccello J; Tsai JM; Agrawal M; Kiel DP; Bouxsein ML; Richards JB; Evans DM; Wein MN; Charles JF; Jaiswal S; Natarajan P; Ebert BL
J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34698806
[TBL] [Abstract][Full Text] [Related]
59. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury.
Vlasschaert C; Robinson-Cohen C; Chen J; Akwo E; Parker AC; Silver SA; Bhatraju PK; Poisner H; Cao S; Jiang M; Wang Y; Niu A; Siew E; Van Amburg JC; Kramer HJ; Kottgen A; Franceschini N; Psaty BM; Tracy RP; Alonso A; Arking DE; Coresh J; Ballantyne CM; Boerwinkle E; Grams M; Zhang MZ; Kestenbaum B; Lanktree MB; Rauh MJ; Harris RC; Bick AG
Nat Med; 2024 Mar; 30(3):810-817. PubMed ID: 38454125
[TBL] [Abstract][Full Text] [Related]
60. Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
Kusne Y; Fernandez J; Patnaik MM
Semin Hematol; 2021 Oct; 58(4):226-229. PubMed ID: 34802544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
